🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥

Startup Showcase

Premium Content

Try our Valuation Calculator →

News on Medial

HRtech firm Darwinbox in talks with KKR at lower valuation

Inshorts · 5m ago

HRtech firm Darwinbox in talks with KKR at lower valuation

Private equity firm KKR is eyeing a stake in Darwinbox, which provides software for HR management. It is expected to lead a deal involving secondary shares. Some of Darwinbox's early investors will offload a tranche of their shares. These include Endiya Partners, which owns an 8% stake, and Lightspeed Venture Partners, which controls around 20%.

3

Related News

Partners Group, KKR lead $140-mn investment in Darwinbox

VCCircle

VCCircle · 4m ago

Partners Group, KKR lead $140-mn investment in Darwinbox

Partners Group and KKR are leading a $140 million investment round in Indian HR tech startup Darwinbox to support its international expansion. This round includes Gravity Holdings and involves both primary and secondary capital. Founded in 2015, Darwinbox offers automation services across the employee lifecycle. The company has previously raised $72 million at a $1 billion valuation and expanded into North America and other markets, achieving significant international revenue growth.

Darwinbox seeks fresh funding upto $150 mn

Inshorts · 4m ago

Darwinbox seeks fresh funding upto $150 mn

HR tech platform DarwinBox is reportedly in talks to raise $120-150 million in a fresh funding round to be led by global private equity firms KKR and Partners Group. As per a Mint report, the round, which will be a mix of primary and secondary infusion, is expected to value the company at around $950 million.

Kaiser may steer $250 million funding in SaaS firm Innovaccer at flat valuation

Economic Times

Economic Times · 1y ago

Kaiser may steer $250 million funding in SaaS firm Innovaccer at flat valuation

US health and insurance company Kaiser Permanente is in talks to lead a $200-250 million investment in healthcare SaaS firm Innovaccer, with a mix of primary and secondary funding. The secondary transaction is expected to be at a lower valuation than the company's peak valuation of $3.2 billion in December 2021. This reflects a trend in lower valuation multiples for SaaS companies globally, with valuations now trending at 10-15x revenue multiples. Innovaccer works with leading healthcare firms in the US to digitize patient data records and improve care quality at lower costs.

Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask

VCCircle

VCCircle · 9m ago

Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask

Private equity firm KKR is exploring alternative options to monetize its investment in JB Chemicals & Pharmaceuticals Ltd, also known as JB Pharma. Talks to sell its stake in the drugmaker have hit a roadblock due to differences in valuation. KKR is now considering a multi-billion dollar plan to unlock the value of its investment in JB Pharma.

HR services SaaS company Darwinbox raises $140 million from Partners Group, KKR, others

Economic Times

Economic Times · 4m ago

HR services SaaS company Darwinbox raises $140 million from Partners Group, KKR, others

Darwinbox, a SaaS HR-services unicorn, raised $140 million from Partners Group, KKR, and others, valuing it around $950 million. Founded in 2015, the company serves over 1,000 enterprises globally. The latest funding, primarily secondary with some primary investment, will focus on R&D and international expansion. Darwinbox emphasizes AI innovation and payroll investment, generating 70% of revenue from new clients. The firm aims for over 50% revenue growth in FY25, with significant contributions from international markets.

Zepto eyes capital raise; KKR in talks with Torrent for JB Pharma stake sale

VCCircle

VCCircle · 1y ago

Zepto eyes capital raise; KKR in talks with Torrent for JB Pharma stake sale

Quick commerce startup Zepto is reportedly in talks to raise over $300 million in funding from global investors to support its expansion plans. The Mumbai-based company, which currently has a valuation of $1.4 billion, aims to reach a valuation target of $2.5-3 billion. Zepto aims to achieve EBITDA positivity by September. In other news, private equity firm KKR is reportedly in discussions with Torrent Pharmaceuticals for a potential stake sale in JB Pharma.

HRtech unicorn Darwinbox’s FY23 loss surges 2.4X to INR 158 Cr

Inc42 · 1y ago

HRtech unicorn Darwinbox’s FY23 loss surges 2.4X to INR 158 Cr

HRtech unicorn Darwinbox reported a consolidated net loss of INR 158.25 crore in FY23, a significant increase from INR 65.72 crore in the previous fiscal year. Despite nearly doubling its operating revenue to INR 224.04 crore, the startup's expenses also increased to INR 407.22 crore in FY23. Darwinbox offers cloud-based HR solutions to companies across various functions. The startup aims to achieve profitability in its India operations by 2023 and is planning for a public listing by 2025.

Mizuho is in talks to buy KKR’s part stake in fintech company InCred

Economic Times

Economic Times · 1y ago

Mizuho is in talks to buy KKR’s part stake in fintech company InCred

Japan's Mizuho Financial Group is reportedly in talks to acquire a stake in Indian financial services unicorn InCred Finance. The discussions involve purchasing a portion of the stake currently held by global investment firm KKR, potentially amounting to around 10%. The negotiations are said to be at a premium to InCred's last valuation of $1.2 billion. Other investors are also considering a secondary stake purchase ahead of a potential IPO by InCred in the next one to two years.

KKR Plans Re Sustainability Split, to Monetise Some Ops; Tata Sons charts out big digital invest

VCCircle

VCCircle · 1y ago

KKR Plans Re Sustainability Split, to Monetise Some Ops; Tata Sons charts out big digital invest

Private equity firm KKR intends to restructure and monetize its industrial waste management business, Re Sustainability Ltd, at a minimum valuation of $1 billion. KKR currently holds a 60% stake in the company and plans to acquire the remaining 40% stake from founder Ayodhya Rami Reddy. In other news, Tata Sons has outlined significant investments in digital ventures.

KKR moves closer to sealing stake sale deal for JB Chemicals

VCCircle

VCCircle · 11m ago

KKR moves closer to sealing stake sale deal for JB Chemicals

Global private equity firm KKR is nearing a deal to sell its stake in Indian pharmaceutical company JB Chemicals & Pharmaceuticals Ltd. After engaging in discussions with multiple potential buyers, KKR is now in advanced talks with a company for the sale of its stake. The Mumbai-listed JB Chemicals has been the subject of interest from various suitors.

Trackers

Active Indian VC’s

OG Capital Email

With a hands-on approach, OG Capital aims to invest in over 20 promising...

Accel Partners Email

Early and growth-stage investments in disruptive technology companies with...

Early-stage venture capital firm investing in technology startups in India. Focus on...

Access All Trackers

Startup Showcase Winners

June 2025

Helping your parents when you are miles away

The Pit Stop Your Cravings Deserve

The next generation E-commerce platform

Enter Ongoing Startup Showcase

Top Users

Trending News on Medial

'We are busy building Bhujia comp ...

Railways launches RailOne Super A ...

All In Capital launches The Eleva ...

Download the medial app to read full posts, comements and news.